Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Assembly Biosciences (ASMB) Drug Pipeline

Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Abi-6250Mild Hepatic ImparementPhase INot Yet RecruitingA Study to Assess the Safety, Tolerability and Pharmacokinetics of ABI-6250 in Participants With Mild Hepatic Impairment Compared With Participants With Normal Hepatic FunctionSep 14, 2026―
Abi-6250Hepatitis Delta Virus, Hepatitis DPhase ICompletedA Study to Assess the Safety, Tolerability and Pharmacokinetics of ABI-6250 in Healthy ParticipantsDec 13, 2024
Abi-1179Recurrent Genital Herpes Simplex Type 2Phase ICompletedA Study to Assess the Safety, Pharmacokinetics, and Tolerability of ABI-1179 in Healthy Subjects and in Subjects Seropositive for HSV-2 With Recurrent Genital HerpesNov 08, 2024
Abi-4334Chronic Hepatitis BPhase ICompletedA Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-4334 in Subjects With Chronic Hepatitis B Virus InfectionApr 22, 2024―
Abi-5366Recurrent Genital Herpes Simplex Type 2Phase IRecruitingA Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of ABI-5366 in Healthy Participants and Participants Seropositive for HSV-2 With Recurrent Genital HerpesApr 18, 2024

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Assembly Biosciences Inc (ASMB) have in its pipeline
Assembly Biosciences ASMB is currently developing the following drugs: Abi-6250, Abi-1179, Abi-4334, Abi-5366. These drug candidates are in various stages of clinical development as the company works toward FDA approval.